Question 1

Am I eligible for this trial based on my melanoma type and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients clinical trial (NCT00936221). Contact the study team or your healthcare provider for specific answers.

Question 2

How does AZD6244 compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients clinical trial (NCT00936221). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from AZD6244 and dacarbazine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients clinical trial (NCT00936221). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients clinical trial (NCT00936221). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients clinical trial (NCT00936221). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any additional support available for travel or logistics if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients clinical trial (NCT00936221). Contact the study team or your healthcare provider for specific answers.

What this study is about